A Dark Vector Cognition product

Item 1. Legal Proceedings

2K characters. Original on sec.gov · Markdown

Item 1. Legal Proceedings

Abbott is involved in various claims, legal proceedings and investigations as described in our Annual Report on Form 10-K for the year ended December 31, 2021 and our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2022.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

(c)Issuer Purchases of Equity Securities

Period(a) Total Number of Shares (or Units) Purchased**(1)**(b) Average Price Paid per Share (or Unit)(c) Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs(d) Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs**(2)**
July 1, 2022 - July 31, 2022—$——$3,981,169,070
August 1, 2022 - August 31, 20221,050,000102.5671,050,0003,873,473,475
September 1, 2022 - September 30, 20227,363,597102.8957,363,5973,115,796,433
Total8,413,597$102.8548,413,597$3,115,796,433

1.These shares do not include the shares surrendered to Abbott to satisfy tax withholding obligations in connection with the vesting of restricted stock or restricted stock units.

2.On December 10, 2021, the board of directors authorized the repurchase of up to $5 billion of Abbott common shares, from time to time.

Previous: Item 4. Controls and Procedures · Next: Item 6. Exhibits